Recently, the "2010 China Pharmaceutical Corporate Social Responsibility Forum and Corporate Social Responsibility Award Award Ceremony" held in Beijing came to an end. Amend Pharmaceutical Group won the "2010 China Pharmaceutical Enterprise Corporate Social Responsibility Excellence Award" and issued the "Beijing Declaration-Proposal for the Implementation of Social Responsibility of Chinese Pharmaceutical Enterprises" together with other award-winning enterprises.
It is reported that the forum was co-organized by China Pharmaceutical Enterprise Management Association, China Foreign Investment Enterprises Association Drug Research and Development Industry Committee and People's Daily. In the forum, 9 companies were awarded the CSR Contribution Award for Pharmaceutical Enterprises, and 10 enterprises were awarded the CSR Excellence Award for Pharmaceutical Enterprises.
Consumers first, always insist on conscience medicine, reassurance medicine, and medication
According to the reporter's understanding, since its establishment, Amend Pharmaceutical Group has been adhering to the concept of "repairing the original and improving morals and integrity", and put the health of consumers first. In the respect and cherishment of life, in the attitude of saving the lives and helping the wounds, produce rational medicines from an emotional perspective, "conscience medicines, reassurance medicines, tube medicines"-all the medicines produced by the modified pharmaceutical industry correspond to this. In the process from production to sales, quality is strictly controlled in every link, insisting that the product is unqualified and never leaving the factory, and the effect is inexact and resolutely not producing. This behavior brings light and hope, safety and trust to patients, guarantees Every medicine they take in their mouths is a reassurance medicine and a controlled medicine made by conscience people.
A high sense of social responsibility, a corporate culture of "relieving the world by treating diseases and saving people," and a spirit of dedication have enabled the correction pharmaceutical industry to grow into a large-scale pharmaceutical and health enterprise. In the 15 years since its establishment, Amend Pharmaceutical Group has developed into a large-scale modern pharmaceutical enterprise group integrating scientific research, production and marketing, with more than 50,000 employees, total assets of 4.5 billion yuan, and sales of 11.5 billion yuan in 2009, becoming China's pharmaceutical industry. Leading enterprise. And its medicines have been favored by countless consumers. At the same time that Amend Pharmaceutical won the title of "China Drug Store's Ten-Year Gold Medal Supplier", "Sdashu", "Xiaomishuan", "Weidaning", " "Neck waist" and other products have also won "high clerk recommendation rate brand." In 2010, "Stashu" won the annual "Popular Gastroenterology" award again.
When asked what strategic measures will be taken in the "Twelfth Five-Year Plan", the person in charge of Amendment Pharmaceuticals stated that during the "Twelfth Five-Year Plan" period, Amendment Pharmaceuticals Group will closely follow the development of medical reform and the medical situation and implement it. Implement various policies and strategies formulated by the state, achieve the goal of over 100 billion sales in 2015, and produce more conscience medicines, reassurance medicines, and controlled medicines that are popular with consumers, such as "Starco".
Dedicate to public welfare, implement corporate social responsibility, and be a benchmark enterprise for social responsibility
As a very large pharmaceutical company in China, Revised Pharmaceuticals has established the corporate tenet of "repairing the original and benefiting people" since its establishment. Always regard the practice of "Bethune's spirit" as the primary social responsibility, and have undoubtedly become the advocate of Chinese caring pharmaceutical companies. At the critical junctures such as the flood fighting in 1998, the fight against SARS, the "5.12" earthquake and the floods in Jilin, the amended pharmaceutical industry stepped forward and brought into play the social responsibility that pharmaceutical companies should assume. It is reported that over the past ten years, Amendment Pharmaceutical has actively participated in many social public welfare undertakings. So far, various direct donations have accumulated more than 500 million yuan. At the same time, Amend Pharmaceutical Group was titled "China Charity Star Enterprise" by the outside world.
According to related reports, in 2010, the amendment of the pharmaceutical industry for the benefit of people and the service of the community put forward the concept of a large health industry, and spared no effort in social welfare. This year, Amendment Pharmaceutical Group, as the main organizer of the national donation activity of the "Bethune Love Book Garden", donated 300,000 Bethune love bookshelves (bags) and books at the ceremony, worth 100 million yuan, and was awarded by the Bethune Fund Management Committee "Love Partner" title.
As we all know, corporate social responsibility is an important cornerstone for a country and a nation to become strong, and it is also an indispensable factor for the healthy development of a corporate brand. For many years, Amend Pharmaceutical has insisted on and actively fulfilled its social responsibility and served the public health. It not only provides other companies with a model for corporate social responsibility development, but also serves as a benchmark for the social responsibility of the pharmaceutical industry. Resources further promote social harmony and the well-being of the people.